Skip to content
Search

Latest Stories

Say no to e-cigarettes: Vaping linked to higher risk of heart failure

Say no to e-cigarettes: Vaping linked to higher risk of heart failure

Those who use e-cigarettes or vapes are also more likely to suffer from heart attacks, coronary artery disease and depression 

In response to the concerning surge in youth vaping, the UK government in January announced its decision to ban disposable vapes as a measure to safeguard the health of children.


Prime Minister Rishi Sunak stated that while the long-term impacts of vaping were uncertain, the nicotine present in these products can be highly addictive. Therefore, he emphasised that “marketing vapes to children is not acceptable.”

Now, there’s a stronger reason to crack down on vape sales as a new study has revealed that vaping or the use of e-cigarettes may increase the risk of developing heart failure.

The study, which involved 175,000 adults in the United States, found that those who use e-cigarettes were 19 per cent more likely to develop heart failure over a four-year period.

Dr Yakubu Bene-Alhasan, lead author of the study, from MedStar Health in Baltimore, underscored that an increasing number of studies are linking e-cigarettes with harmful effects, suggesting vaping “might not be as safe as previously thought.”

With further research, Dr Bene-Alhasan’s team plans to uncover “a lot more about the potential health consequences and improve the information out to the public.”

They are presenting their study findings at an American College of Cardiology meeting this weekend.

Earlier, a study led by the University of Kansas School of Medicine Wichita found vaping associated with heart attacks, coronary artery disease and depression.

Those who use e-cigarettes were found to be 56 per cent more likely to have a heart attack, 30 percent more likely to suffer a stroke, compared with nonusers.

Coronary artery disease and circulatory problems, including blood clots, were also significantly more prevalent among e-cigarette users, with a 10 percent and 44 percent higher occurrence, respectively. Additionally, this group experienced a twofold increase in the likelihood of experiencing depression, anxiety, and other emotional problems.

Previous research shows that adults who report puffing e-cigarettes, or vaping, are significantly more likely to have a heart attack, coronary artery disease and depression compared with those who don't use them or any tobacco products.

Vaping can serve as a useful tool to quit smoking, which is considered the single largest preventable cause of death in England. However, there is a worrying trend of children increasingly resorting to these highly addictive alternatives, many of which are evidently designed to attract young people.

According to official statistics, the prevalence of vape usage among children in the UK has tripled within the last three years, now affecting nine per cent of 11 to 15-year-olds. Disposable vapes are thought to be the primary factor fueling the alarming increase in youth vaping, with the number of 11 to 17-year-olds using disposable devices estimated to have increased almost ninefold in the past two years.

 

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less